Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Potential for airway smooth muscle as therapeutic target is reflected in the breadth of expertise of next generation scientists.

Halayko AJ, Stewart AG.

Pulm Pharmacol Ther. 2013 Feb;26(1):1-2. doi: 10.1016/j.pupt.2012.10.003. Epub 2012 Oct 24. No abstract available.

PMID:
23103803
2.

Emerging airway smooth muscle targets to treat asthma.

Siddiqui S, Redhu NS, Ojo OO, Liu B, Irechukwu N, Billington C, Janssen L, Moir LM.

Pulm Pharmacol Ther. 2013 Feb;26(1):132-44. doi: 10.1016/j.pupt.2012.08.008. Epub 2012 Sep 7. Review.

PMID:
22981423
3.

Asthma therapy: how far have we come, why did we fail and where should we go next?

Janssen LJ.

Eur Respir J. 2009 Jan;33(1):11-20. doi: 10.1183/09031936.00068508. Review.

4.

Drug treatment of airway inflammation in asthma.

Blake KV.

Pharmacotherapy. 2001 Mar;21(3 Pt 2):3S-20S. Review.

PMID:
11253868
5.

Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?

Wright DB, Meurs H, Dekkers BG.

Trends Pharmacol Sci. 2014 Nov;35(11):567-74. doi: 10.1016/j.tips.2014.09.006. Epub 2014 Oct 16. Review.

PMID:
25441775
6.

Phosphodiesterase inhibitors: knockout drops?

Raeburn D, Karlsson JA.

J Pharm Pharmacol. 1997 May;49 Suppl 3:19-24. Review. No abstract available.

PMID:
9178203
7.

RhoA, a possible target for treatment of airway hyperresponsiveness in bronchial asthma.

Chiba Y, Matsusue K, Misawa M.

J Pharmacol Sci. 2010;114(3):239-47. Epub 2010 Oct 8. Review.

8.

Direct effects of Th2 cytokines on airway smooth muscle.

Shore SA.

Curr Opin Pharmacol. 2004 Jun;4(3):235-40. Review.

PMID:
15140414
9.

Mechanisms of airway hyperresponsiveness in asthma.

Berend N, Salome CM, King GG.

Respirology. 2008 Sep;13(5):624-31. doi: 10.1111/j.1440-1843.2008.01330.x. Review.

PMID:
18713086
10.

ADAM33: a novel therapeutic target for asthma.

Powell RM, Hamilton LM, Holgate ST, Davies DE, Holloway JW.

Expert Opin Ther Targets. 2003 Aug;7(4):485-94. Review.

PMID:
12885268
11.

Airway smooth muscle: a potential target for asthma therapy.

Dowell ML, Lavoie TL, Solway J, Krishnan R.

Curr Opin Pulm Med. 2014 Jan;20(1):66-72. doi: 10.1097/MCP.0000000000000011. Review.

PMID:
24247041
12.

Does bronchial hyperresponsiveness in asthma matter?

Currie GP, Jackson CM, Lipworth BJ.

J Asthma. 2004;41(3):247-58. Review.

PMID:
15260457
13.

[The hypersensitive bronchial system. Significance for prognosis inhibition of progression of chronic obstructive respiratory tract diseases].

Nowak D, Magnussen H.

Internist (Berl). 1993 Apr;34(4):294-9. Review. German. No abstract available.

PMID:
8486472
14.

Airway smooth muscle as a model for new investigative drugs in asthma.

Baroffio M, Crimi E, Brusasco V.

Ther Adv Respir Dis. 2008 Jun;2(3):129-39. doi: 10.1177/1753465808091154. Review.

PMID:
19124365
15.

Rho-kinase as a drug target for the treatment of airway hyperrespon-siveness in asthma.

Gosens R, Schaafsma D, Nelemans SA, Halayko AJ.

Mini Rev Med Chem. 2006 Mar;6(3):339-48. Review.

PMID:
16515473
16.

Apoptosis, airway inflammation and anti-asthma therapy: from immunobiology to clinical application.

Spinozzi F, de Benedictis D, de Benedictis FM.

Pediatr Allergy Immunol. 2008 Jun;19(4):287-95. doi: 10.1111/j.1399-3038.2007.00668.x. Epub 2008 Jan 7. Review.

PMID:
18179617
17.

Airway smooth muscle: immunomodulatory cells?

Panettieri RA Jr.

Allergy Asthma Proc. 2004 Nov-Dec;25(6):381-6. Review.

PMID:
15709448
18.

Frozen objects: small airways, big breaths, and asthma.

Fredberg JJ.

J Allergy Clin Immunol. 2000 Oct;106(4):615-24. Review.

PMID:
11031329
19.

Airway hyperresponsiveness: new insights into the pathogenesis.

Lommatzsch M.

Semin Respir Crit Care Med. 2012 Dec;33(6):579-87. doi: 10.1055/s-0032-1325617. Epub 2012 Oct 9. Review.

PMID:
23047309
20.

Supplemental Content

Support Center